Treatment depends substantially on the type of ICH. Rapid
CT scan and other diagnostic measures are used to determine proper treatment, which may include both medication and surgery. •
Tracheal intubation is indicated in people with decreased level of consciousness or other risk of airway obstruction. Early lowering of the blood pressure can reduce the volume of the haematoma, but may not have any effect against the oedema surrounding the haematoma. Reducing the blood pressure rapidly does not cause
brain ischemia in those who have intracerebral haemorrhage. The
American Heart Association and
American Stroke Association guidelines in 2015 recommended decreasing the blood pressure to a SBP of 140 mmHg. Giving
Factor VIIa within 4 hours limits the bleeding and formation of a
hematoma. However, it also increases the risk of
thromboembolism. It thus overall does not result in better outcomes in those without hemophilia.
Frozen plasma,
vitamin K,
protamine, or
platelet transfusions may be given in case of a
coagulopathy. The specific reversal agents
idarucizumab and
andexanet alfa may be used to stop continued intracerebral hemorrhage in people taking directly oral acting anticoagulants (such as factor Xa inhibitors or direct thrombin inhibitors). H2 antagonists or proton pump inhibitors are commonly given to try to prevent
stress ulcers, a condition linked with ICH.
Surgery Surgery is required if the
hematoma is greater than , if there is a structural
vascular lesion or
lobar hemorrhage in a young patient. Aspiration by
stereotactic surgery or
endoscopic drainage may be used in
basal ganglia hemorrhages, although successful reports are limited. ==Prognosis==